|
TMEM194A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62581059726108E-12 |
| Normal-vs-Stage2 |
8.4508999997901E-07 |
| Normal-vs-Stage3 |
3.96449999495729E-08 |
| Normal-vs-Stage4 |
1.86660000012218E-07 |
| Stage1-vs-Stage2 |
3.773800E-01 |
| Stage1-vs-Stage3 |
1.785560E-01 |
| Stage1-vs-Stage4 |
3.034800E-01 |
| Stage2-vs-Stage3 |
9.230000E-02 |
| Stage2-vs-Stage4 |
8.619600E-01 |
| Stage3-vs-Stage4 |
7.601900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
5.738100E-03 |
| Normal-vs-Asian |
6.176000E-03 |
| Caucasian-vs-AfricanAmerican |
9.013800E-04 |
| Caucasian-vs-Asian |
1.174630E-01 |
| AfricanAmerican-vs-Asian |
1.844420E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62714286489063E-12 |
| Normal-vs-Female |
1.64546154479694E-12 |
| Male-vs-Female |
2.345000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.535790E-02 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
1.70619074424394E-12 |
| Normal-vs-Age(81-100Yrs) |
2.754300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.422000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.780000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.113000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.618200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.683580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.149800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.518700E-03 |
| Normal-vs-Grade 2 |
1.62470037423645E-12 |
| Normal-vs-Grade 3 |
2.22866169963254E-12 |
| Normal-vs-Grade 4 |
1.809260E-04 |
| Grade 1-vs-Grade 2 |
2.785200E-01 |
| Grade 1-vs-Grade 3 |
7.775800E-02 |
| Grade 1-vs-Grade 4 |
3.476600E-01 |
| Grade 2-vs-Grade 3 |
1.473180E-01 |
| Grade 2-vs-Grade 4 |
6.583600E-01 |
| Grade 3-vs-Grade 4 |
7.671200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.27030053143073E-10 |
| ccA subtype-vs-ccB subtype |
2.367700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
2.022300E-02 |
| N0-vs-N1 |
2.509200E-01 |
|
|
